4//SEC Filing
ROSENWALD LINDSAY A MD 4
Accession 0001104659-24-078786
CIK 0001429260other
Filed
Jul 9, 8:00 PM ET
Accepted
Jul 10, 8:30 AM ET
Size
5.6 KB
Accession
0001104659-24-078786
Insider Transaction Report
Form 4
ROSENWALD LINDSAY A MD
Director
Transactions
- Purchase
SERIES A CUMULATIVE PERPETUAL PREFERRED STOCK
2024-07-08$7.35/sh+5,000$36,765→ 117,500 total
Footnotes (1)
- [F1]Reflects the weighted average sale price of multiple same-way open market sale transactions effected by the Reporting Person on the same day at different prices through a sale order executed by a broker-dealer. The Reporting Person reported on a single line all such transactions that occurred within a one-dollar price range. The range of prices for the sale transactions on July 8, 2024 was $7.29 to $7.47. The Reporting Person hereby undertakes to provide upon request by the Securities Exchange Commission staff, the Issuer, or a stockholder of the Issuer, full information regarding the number of shares sold at each separate price.
Documents
Issuer
Fortress Biotech, Inc.
CIK 0001429260
Entity typeother
Related Parties
1- filerCIK 0000941841
Filing Metadata
- Form type
- 4
- Filed
- Jul 9, 8:00 PM ET
- Accepted
- Jul 10, 8:30 AM ET
- Size
- 5.6 KB